celecoxib has been researched along with Stevens-Johnson Syndrome in 7 studies
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study is to review cases of Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the FDA associated with the use of the selective COX-2 inhibitor NSAIDs celecoxib, rofecoxib and valdecoxib, and to compare reporting rates of the two conditions associated with these drugs to each other, meloxicam (an oxicam NSAID that came on the US market at a similar time) and the background incidence rate." | 3.73 | Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. ( Bonnel, R; Brinker, A; Governale, L; Karwoski, C; La Grenade, L; Lee, L; Weaver, J, 2005) |
| "A 41-year-old woman was given celecoxib (Celebrex) for the treatment of carpal tunnel syndrome." | 3.71 | Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). ( Friedman, B; Law, E; Orlet, HK; Still, JM, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, P | 1 |
| Dwyer, D | 1 |
| Corallo, CE | 1 |
| Friedman, B | 1 |
| Orlet, HK | 1 |
| Still, JM | 1 |
| Law, E | 1 |
| Giglio, P | 1 |
| Perna, AG | 1 |
| Woodruff, CA | 1 |
| Markus, RF | 1 |
| Hsu, S | 1 |
| Schmutz, JL | 1 |
| Barbaud, A | 1 |
| Trechot, P | 1 |
| La Grenade, L | 1 |
| Lee, L | 1 |
| Weaver, J | 1 |
| Bonnel, R | 1 |
| Karwoski, C | 1 |
| Governale, L | 1 |
| Brinker, A | 1 |
| Layton, D | 1 |
| Marshall, V | 1 |
| Boshier, A | 1 |
| Friedmann, P | 1 |
| Shakir, SA | 1 |
1 review available for celecoxib and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Toxic epidermal necrolysis as a complication of treatment with celecoxib.
Topics: Aged; Aged, 80 and over; Celecoxib; Chemical and Drug Induced Liver Injury; Cyclooxygenase Inhibitor | 2003 |
6 other studies available for celecoxib and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Toxic epidermal necrolysis after celecoxib therapy.
Topics: Aged; Aged, 80 and over; Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Osteoarthritis; Pyraz | 2002 |
Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carpal Tunnel Syndrome; Celec | 2002 |
Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
Topics: Celecoxib; Cyclooxygenase Inhibitors; Drug Eruptions; Humans; Pyrazoles; Stevens-Johnson Syndrome; S | 2003 |
[Toxic epidermal necrolysis and celecoxib (Celebrex)].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Humans; Pyrazoles; Stevens-Johnson Syndrome; Sul | 2004 |
Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Celecoxib; Cycl | 2005 |
Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Celecoxib; Cyclooxygenase 2 | 2006 |